Comparative effectiveness of HMA with venetoclax vs intensive chemotherapy in AML with very high-risk cytogenetics
HMA联合维奈托克与强化化疗治疗极高危细胞遗传学AML的疗效比较
期刊:
影响因子:
doi:10.1016/j.bneo.2026.100201
Aguirre, Luis E; Bewersdorf, Jan Philipp; Liu, Yiwen; Shallis, Rory M; Boussi, Leora; Zucenka, Andrius; Garciaz, Sylvain; Bystrom, Rebecca P; DeAngelo, Daniel J; Stone, Richard M; Luskin, Marlise R; Garcia, Jacqueline S; Winer, Eric S; Ling, Kelly; Chen, Evan C; Wadleigh, Martha; Berton, Guillaume; Stein, Eytan M; Goldberg, Aaron D; Mendez, Lourdes; Zeidan, Amer M; Sallman, David A; Shimony, Shai; Stahl, Maximilian